You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日總結》恆指升6點 阿裏巴巴跌逾4% 基建股受捧
港股反覆靠穩,恆指高開36點後轉跌,曾跌207點見24,365點,其後跌幅收窄,收市升6點或0.03%,報24,579點;國指升5或0.06%,收8,589點;恆生科技指數跌52點或0.93%,收5,529點。大市全日成交總額1,223.09億元,滬、深港通分別淨流入2,310萬及25.97億元人民幣。 科技股方面,阿裏巴巴(09988.HK)擬額外註冊10億份美國預託證券,股價跌4.5%報115元。騰訊(00700.HK)跌0.2%報478元,小米(01810.HK)跌1.2%報16.38元,美團(03690.HK)、快手(01024.HK)及網易(09999.HK)各跌0.3%至0.4%,京東(09618.HK)升2.6%報292.2元。 手機相關股比亞迪電子(00285.HK)、瑞聲(02018.HK)及丘鈦(01478.HK)各跌3.3%至4.3%。電訊設備股中興(00763.HK)跌3.7%。電訊股見追捧,中移動(00941.HK)升3%報56元,中電信(00728.HK)及聯通(00762.HK)各升3.3%及2.1%。 基建及水泥股受捧,中交建(01800.HK)及中鐵建(01186.HK)各升8.5%及5.4%,中建材(03323.HK)、海螺水泥(00914.HK)及中國通號(03969.HK)各升逾3%。 醫藥股藥明生物(02269.HK)料去年純利按年增長逾98%,全日股價升1.3%。開拓藥業(09939.HK)治療脫髮和痤瘡藥於美國I期臨牀試驗完成首例受試者給藥,股價急漲25.3%報10元。 內房股中國金茂(00817.HK)分拆之金茂物業服務通過上市聆訊,股價跌1.4%報2.83元。本港新冠疫情惡化,九倉置業(01997.HK)跌1.8%,港鐵(00066.HK)亦跌1%。內需股農夫山泉(09633.HK)及中國飛鶴(06186.HK)各跌5.1%及5.3%、潤啤(00291.HK)跌2.5%。 金融股匯控(00005.HK)平收57.9元,港交所(00388.HK)及友邦(01299.HK)各升0.7%及0.1%,中銀香港(02388.HK)升2.6%。內銀股建行(00939.HK)、農行(01288.HK)、工行(01398.HK)、民行(01988.HK)、招行(03968.HK)及中行(03988.HK)各升1.3%至1.7%。 紐約期油升穿每桶90美元,中石油(00857.HK)及中海油(00883.HK)各升3.3%及4.2%,油服股中海油服(02883.HK)及安東油服(03337.HK)各升6%及4.1%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account